home / lobbying

lobbying_activities

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

915 rows where filing_year = 2009 and issue_code = "PHA" sorted by filing_year descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: filing_type, is_termination

filing_period 4

  • first_quarter 247
  • second_quarter 234
  • fourth_quarter 221
  • third_quarter 213

issue_code 1

  • PHA · 915 ✖

filing_year 1

  • 2009 · 915 ✖
id filing_uuid filing_type registrant_name registrant_id client_name filing_year ▲ filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
743680 RUBICON ADVISORS, LLC 9d7e8c3d-2b56-4810-8499-012c982b3214 3A RUBICON ADVISORS, LLC 315091 GILEAD SCIENCES 2009 third_quarter PHA H.R. 822, H.R. 1943, H.R. 6114, S-2969   75000   0 0 2009-02-10T20:06:50-05:00
743681 RUBICON ADVISORS, LLC c15a1a3d-82cb-416d-ab9d-0ae3f39c4b25 1A RUBICON ADVISORS, LLC 315091 GILEAD SCIENCES 2009 first_quarter PHA H.R. 822, H.R. 1943, H.R. 6114, S-2969   75000   0 0 2009-02-10T20:08:50-05:00
743682 RUBICON ADVISORS, LLC e3fa9c29-7b9e-419f-a67a-d5beb5a109b0 2A RUBICON ADVISORS, LLC 315091 GILEAD SCIENCES 2009 second_quarter PHA H.R. 822, H.R. 1943, H.R. 6114, S-2969   75000   0 0 2009-02-10T20:11:51-05:00
743916 HOLLAND & KNIGHT LLP d855cceb-2420-4dd5-a47a-c5ad3c3be488 Q1 HOLLAND & KNIGHT LLP 18466 AMERICAN SOCIETY OF HEMATOLOGY 2009 first_quarter PHA Hematology and Oncology drug research and approval issues. Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 20000   0 0 2009-03-25T11:34:28-04:00
743925 HOLLAND & KNIGHT LLP e44a52a6-a84a-4014-89b6-d0db2d3e6f52 Q1 HOLLAND & KNIGHT LLP 18466 NATIONAL HEMOPHILIA FOUNDATION 2009 first_quarter PHA Blood and blood product safety; issues related to blood product approvals. Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 40000   0 0 2009-03-25T12:04:34-04:00
744097 CYBER SECURITY RESEARCH CONSULTANTS, LLC ff534b94-18e2-482a-b838-7cc13e03433f Q1 CYBER SECURITY RESEARCH CONSULTANTS, LLC 91694 PDFRAZER CONSULTING INC CANADIAN INTERNATIONAL PHARMACY ASSOCIATION 2009 first_quarter PHA Food and Drug Safety Globalization Act Monitoring Dorgan-Snowe drug reimportation from Canada HOUSE OF REPRESENTATIVES,SENATE 15000   0 0 2009-03-31T19:49:29-04:00
744289 HOLLAND & KNIGHT LLP 15ef8fc3-fada-496c-afce-ab342b928afb Q1 HOLLAND & KNIGHT LLP 18466 BIOTECHNOLOGY INDUSTRY ORGANIZATION 2009 first_quarter PHA Issues relating to the biotechnology industry. HOUSE OF REPRESENTATIVES,SENATE 90000   0 0 2009-04-02T09:45:10-04:00
745724 SQUIRE PATTON BOGGS 86ba574c-8de6-4954-83db-abc82765e3cd Q1 SQUIRE PATTON BOGGS 30906 KERR CORPORATION 2009 first_quarter PHA FDA enforcement action against counterfeits of client's medical devices. HOUSE OF REPRESENTATIVES 10000   0 0 2009-04-08T11:52:47-04:00
746341 EXPRESS SCRIPTS, INC. 34e3f6de-d8a6-40f1-96f1-09202886c1fb Q1 EXPRESS SCRIPTS, INC. 294416 EXPRESS SCRIPTS, INC. 2009 first_quarter PHA Items related to reverse settlement payments between manufacturers, H.R. 1706 Congressional Budget Office (CBO),Defense, Dept of (DOD),Federal Trade Commission (FTC),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),Office of Management & Budget (OMB),SENATE   250000 0 0 2009-04-09T15:04:12-04:00
746618 VENABLE LLP d3e63136-0483-4ac3-b600-988833d4688c Q1 VENABLE LLP 39941 ENDO PHARMACEUTICALS INC 2009 first_quarter PHA General issues affecting the pharmaceutical industry. HOUSE OF REPRESENTATIVES,SENATE     0 0 2009-04-10T10:43:47-04:00
746675 INDEPENDENT PHARMACY COOPERATIVE 483b42ca-fec1-4a9e-80ac-3fdcb1d4375a Q1 INDEPENDENT PHARMACY COOPERATIVE 313098 INDEPENDENT PHARMACY COOPERATIVE 2009 first_quarter PHA Average Manufacturers Price Pharmacy Reimbursement S. 511 and H.R. 616 Preserve Patient Access DMEPOS Accreditation HOUSE OF REPRESENTATIVES,SENATE   10000 0 0 2009-04-10T11:26:49-04:00
746879 DUTKO WORLDWIDE, LLC a48fe2ad-d8f8-472d-b47c-4c4eb7e38306 Q1 DUTKO WORLDWIDE, LLC 12868 IBIS BIOSCIENCES 2009 first_quarter PHA Counsel and advise client regarding attempts to secure federal procurement contracts for biosensor device. Agriculture, Dept of (USDA),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA) 10000   0 0 2009-04-10T14:54:07-04:00
746949 DUTKO WORLDWIDE, LLC 594a3772-fbf0-4897-8e1b-b1382e3a5ccd Q1 DUTKO WORLDWIDE, LLC 12868 NEWAYS INTERNATIONAL 2009 first_quarter PHA Monitor legislation pertaining to dietary supplements and pharmaceuticals, particularly the Food Safety Modernization Act (S. 510). Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2009-04-10T15:42:43-04:00
747087 BROWNSTEIN HYATT FARBER SCHRECK, LLP da94379d-14fa-4738-8165-5a45104159d4 Q1 BROWNSTEIN HYATT FARBER SCHRECK, LLP 7257 JOHNSON & JOHNSON SERVICES, INC. 2009 first_quarter PHA Follow-on Biologics FDA medical device approval Cancer screening Pre-emption; legal reform HOUSE OF REPRESENTATIVES,SENATE 90000   0 0 2009-04-10T18:09:30-04:00
747617 WINBORN SOLUTIONS LLC 19240150-60dd-4682-a076-7fd6881947e5 Q1 WINBORN SOLUTIONS LLC 308310 PERRIGO CO 2009 first_quarter PHA Dextromethorphan Distribution Act of 2009 Food and drug safety, user fee, and country of origin legislation HOUSE OF REPRESENTATIVES,SENATE 18000   0 0 2009-04-13T10:18:01-04:00
747673 POLICY ADVOCATES 4ecb3ed0-7df6-43b0-bc9f-29da3f64b485 Q1 POLICY ADVOCATES 72018 PHOENIX CAPITAL MANAGEMENT LLC 2009 first_quarter PHA Track and monitor Internet Pharmacy Issues. HOUSE OF REPRESENTATIVES,SENATE 7500   0 0 2009-04-13T10:57:25-04:00
747823 ATRIUM HEALTH-FORMERLY KNOWN AS CAROLINAS HEALTHCARE SYSTEM a8698a09-54b0-42bd-ba07-02cdd57b816b Q1 ATRIUM HEALTH-FORMERLY KNOWN AS CAROLINAS HEALTHCARE SYSTEM 58534 ATRIUM HEALTH - FORMERLY KNOWN AS CAROLINAS HEALTHCARE SYSTEM 2009 first_quarter PHA H.R. 444; H1 To amend section 340B of the Public Health Service Act to revise and expand the drug discount program under that section to improve the provision of discounts on drug purchases for certain safety net providers, any language expanding 340B drug discounts to inpatient settings. HOUSE OF REPRESENTATIVES,SENATE   41044 0 0 2009-04-13T12:22:02-04:00
748132 MR. THEODORE (TED) JONES f8668df5-c3c1-4c35-8fcc-93bc0102971a Q1 MR. THEODORE (TED) JONES 20926 PHARMACEUTICAL RESEARCH AND MANUFACTURES OF AMERICA 2009 first_quarter PHA Trade Association for certain Pharmaceutical Companies HOUSE OF REPRESENTATIVES,SENATE 15000   0 0 2009-04-13T16:39:11-04:00
748223 CGCN GROUP, LLC 2c5af353-8c34-497b-8401-288998789f5a 1T CGCN GROUP, LLC 76992 BARR PHARMACEUTICALS INC (FORMERLY BARR LABORATORIES INC ) 2009 first_quarter PHA H.R. 3161, S. 1859, Funding for the Office of Generic Drugs, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act. H.R. 2900, S. 1082, Food and Drug Administration Reform. HOUSE OF REPRESENTATIVES,SENATE 6500   0 1 2009-04-13T21:42:57-04:00
748521 MICHAEL POLLARD 08e73a0a-4a5a-4443-b6b2-499dfdfaaddb Q1 MICHAEL POLLARD 87836 MEDCO HEALTH SOLUTIONS INC 2009 first_quarter PHA HR 1204--Community Pharmacy Fairness Act of 2009; all sections S. 525---Pharmaceutical Market Access and Drug Safety Act of 2009; all aspects Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2009-04-14T11:37:30-04:00
748590 HOLLAND & KNIGHT LLP 692dd5d3-0032-4107-94b0-b480c6e4da0e 1A HOLLAND & KNIGHT LLP 18466 BIOTECHNOLOGY INDUSTRY ORGANIZATION 2009 first_quarter PHA Issues relating to the biotechnology industry. HOUSE OF REPRESENTATIVES,SENATE 100000   0 0 2009-04-14T12:11:51-04:00
748685 KIRKLAND & ELLIS LLP f5f4490c-39ed-4794-be9c-cd2bb7273e29 Q1 KIRKLAND & ELLIS LLP 21745 TEVA PHARMACEUTICALS USA 2009 first_quarter PHA House and Senate legislation on biologic medicines. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2009-04-14T13:00:18-04:00
748859 PARRY, ROMANI, DECONCINI & SYMMS a8424dce-b878-4c92-82f8-acb95343f574 Q1 PARRY, ROMANI, DECONCINI & SYMMS 30792 AMERICAN ASSOCIATION FOR HEALTH FREEDOM 2009 first_quarter PHA Support of legislation and efforts to guarantee access by health professionals and patients to medications such as estriol and other compounded preparations. No specific legislation has been introduced yet. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2009-04-14T14:59:05-04:00
749607 NATIONAL ASSOCIATION OF CHAIN DRUG STORES 442f72ae-1735-46ff-895a-6eff5a64bc12 Q1 NATIONAL ASSOCIATION OF CHAIN DRUG STORES 26672 NATIONAL ASSOCIATION OF CHAIN DRUG STORES 2009 first_quarter PHA H.R.1, the American Recovery and Reinvestment Act, as related to health information technology and state Medicaid programs. H.R. 1259, the Dextromethorphan Distribution Act, as related to the abuse of dextromethorphan. H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act, as related to the approval of generic biopharmaceuticals. S. 726, Promoting Innovation and Access to Life-Saving Medicine Act, as related to the approval of generic biopharmaceuticals. H.R. 1450, Counterfeit Drug Prevention Act of 2009, as related to the prosecution of prohibited acts related to prescription drugs. H.R.759, Food and Drug Administration Globalization Act of 2009, as related to the safety of prescription drugs. H.R. 1359, Secure and Responsible Drug Disposal Act of 2009, as related to the role of pharmacy in the disposal of prescription drugs. H.R.616/S.511, Access to Durable Medical Equipment Act, related to the exemption of pharmacies from Medicare accreditation requirements. The Fair Medicaid Drug Payment Act, as related to pharmacy reimbursement in the Medicaid program. Various issues related to the role of pharmacy and pharmacists in healthcare reform, including pharmacy services in the Medicare program. Centers For Medicare and Medicaid Services (CMS),Consumer Product Safety Commission (CPSC),Drug Enforcement Administration (DEA),Environmental Protection Agency (EPA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Natl Drug Control Policy (NDCP),SENATE,White House Office   440000 0 0 2009-04-15T10:23:03-04:00
749741 CAPITOL HILL CONSULTING GROUP 21a67052-bd39-489b-b0b3-4ecfdaee6e17 Q1 CAPITOL HILL CONSULTING GROUP 72053 PURDUE PHARMA LLP 2009 first_quarter PHA Controlled Drug Substances Act (21 USC 13) HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2009-04-15T11:01:58-04:00
750165 MOFFETT GROUP, LLC 689a01c6-c209-4f61-b166-62c51e495e57 Q1 MOFFETT GROUP, LLC 82578 BOEHRINGER INGELHEIM PHARMECEUTICAL 2009 first_quarter PHA Phamaceutical issues, especially with respect to the House Energy and Commerce Committee. HOUSE OF REPRESENTATIVES,SENATE 25000   0 0 2009-04-15T12:35:32-04:00
750440 CAPITOL HILL CONSULTING GROUP 09fe7193-6bcf-43ef-bb5b-8f9e3cd611a6 1T CAPITOL HILL CONSULTING GROUP 72053 DFB PHARMACEUTICALS INC 2009 first_quarter PHA General Pharmaceutical Issues pertaining to the company. No specific legislation HOUSE OF REPRESENTATIVES,SENATE 30000   0 1 2009-04-15T13:49:33-04:00
750829 UPS (UNITED PARCEL SERVICE) 5c36a9f6-e520-46e8-bf82-8af1ef0f5e87 Q1 UPS (UNITED PARCEL SERVICE) 39223 UPS (UNITED PARCEL SERVICE) 2009 first_quarter PHA UPS Supply Chain Solutions Healthcare Issues Federal Aviation Administration (FAA),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Nuclear Regulatory Commission (NRC),SENATE,State, Dept of (DOS),Transportation, Dept of (DOT),Transportation Security Administration (TSA),U.S. Trade Representative (USTR),White House Office   1316426 0 0 2009-04-15T15:38:18-04:00
750872 FOLEY & LARDNER LLP 4bbd70b2-80d5-45b0-809c-16ed766f6b5a Q1 FOLEY & LARDNER LLP 15042 UNITED THERAPEUTICS 2009 first_quarter PHA Approval and funding for development and application of broad spectrum antiviral drugs HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2009-04-15T15:44:06-04:00
750886 POLICY DIRECTIONS INC. 53f2fdd9-1447-4845-aa24-a74a8a6a0ebd Q1 POLICY DIRECTIONS INC. 31747 ALPHARMA INC/PFIZER ANIMAL HEALTH (FORMERLY KNOWN AS ALPHARMA INC ) 2009 first_quarter PHA Antibiotics in animal foods Drug approvals Implementation of: All titles, to end the use of certain antibiotics in animal feed if those antibiotics are used in human medicine. S. 2313/HR3697, all titles, to require the manufacturers of antibiotics used in animal feed to make certain reports to FDA. Legislation to reform FDA regulation of federal imported and domestic food safety with emphasis on those titles related to the import of ingredients for food and drugs, as well as country-of-origin labeling. Monitor legislative and regulatory developments related to the Animal Drug User Fee Act reauthorization, with related developments of the Generic Animal Drug UserFee Act. Monitor developments of the Food & Drug Administrations development of its Advanced Feed Safety System related to the use of animal drugs in livestock and poultry feeds. Agriculture, Dept of (USDA),Environmental Protection Agency (EPA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2009-04-15T15:46:36-04:00
751713 VAN SCOYOC ASSOCIATES 841fde19-630c-48cb-aa1a-9793a5b9f82d Q1 VAN SCOYOC ASSOCIATES 39837 UNIVERSITY OF CONNECTICUT 2009 first_quarter PHA Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2010, FDA salaries and expenses; and extramural research related issues. Public Law 111-8, Omnibus Appropriations Act, FY2009, FDA salaries and expenses; and extramural research related issues. Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2009-04-16T07:46:30-04:00
751857 LATHAM & WATKINS LLP ad276031-df32-4c22-a082-5aaed1c4a268 Q1 LATHAM & WATKINS LLP 22201 AMPHASTAR PHARMACEUTICALS 2009 first_quarter PHA Congressional oversight of the Food and Drug Administration and Environmental Protection Agency EPA rulemaking on CFC propellants Environmental Protection Agency (EPA),Food & Drug Administration (FDA) 10000   0 0 2009-04-16T09:41:17-04:00
751879 LATHAM & WATKINS LLP f2b24998-0748-400f-92ea-e6afcc6ff068 Q1 LATHAM & WATKINS LLP 22201 ORCHID CHEMICALS & PHARMACEUTICALS LTD 2009 first_quarter PHA Food and Drug Administration policy. Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2009-04-16T09:49:24-04:00
751887 SQUIRE PATTON BOGGS 59a843e1-49d0-4cde-8f3f-40c96df6cf3b Q1 SQUIRE PATTON BOGGS 30906 SUNOVION PHARMACEUTICALS INC 2009 first_quarter PHA Issues related to inhalation drugs, including Xopenex. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2009-04-16T09:52:42-04:00
752013 HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) 7d52b1d5-d89e-4689-8238-04fe9a9e9ae3 Q1 HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) 28776 HEALTHCARE DISTRIBUTION ALLIANCE (FORMERLY - HDMA) 2009 first_quarter PHA Importation of prescription drugs (S. 525/H.R. 1298); Import Safety (H.R. 759); Rx Pedigree; Counterfeit Drugs (H.R. 1450); Methamphetamine/Pseudoephedrine Regulation (S. 256); Dextromethorphan Regulation (H.R. 1259) Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE   220000 0 0 2009-04-16T10:24:07-04:00
752581 UNIVERSITY OF CONNECTICUT d6b0e93a-9376-4ce8-acc2-37c89928c67d Q1 UNIVERSITY OF CONNECTICUT 39382 UNIVERSITY OF CONNECTICUT 2009 first_quarter PHA Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2010, FDA salaries and expenses; and extramural research related issues. Public Law 111-8, Omnibus Appropriations Act, FY2009, FDA salaries and expenses; and extramural research related issues. Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE   70000 0 0 2009-04-16T12:21:10-04:00
752798 APTIV, PLC 0c410513-24af-437e-b138-03ca35275613 Q1 APTIV, PLC 49054 APTIV PLC 2009 first_quarter PHA Accessibility of generic drugs e-prescriptions Medical IT Commerce, Dept of (DOC),Defense Advanced Research Projects Agency (DARPA),Defense, Dept of (DOD),Energy, Dept of,Environmental Protection Agency (EPA),Federal Aviation Administration (FAA),Federal Motor Carrier Safety Administration,Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Aeronautics & Space Administration (NASA),Pension Benefit Guaranty Corporation (PBGC),SENATE,State, Dept of (DOS),Transportation, Dept of (DOT),Transportation Security Administration (TSA)   420000 0 0 2009-04-16T13:01:17-04:00
752818 ASSOCIATION OF NATIONAL ADVERTISERS, INC. f3f549fc-61ed-4189-b873-1d04e4f5c6a5 Q1 ASSOCIATION OF NATIONAL ADVERTISERS, INC. 4653 ASSOCIATION OF NATIONAL ADVERTISERS, INC. 2009 first_quarter PHA Proposals to place a moratorium on prescription drug advertising and requiring a "fair balance" between risk and benefit information in prescription drug advertisements Proposals to extend FDA authority to over-the-counter drug advertisements Federal Communications Commission (FCC),Federal Trade Commission (FTC),HOUSE OF REPRESENTATIVES,SENATE   230000 0 0 2009-04-16T13:03:25-04:00
752939 FLYNN & ASSOCIATES, INC. c8e14127-01b5-412d-bb98-c6270e19e81f Q1 FLYNN & ASSOCIATES, INC. 15020 PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION 2009 first_quarter PHA State Childrens Health Insurance Program Patent Reform Legislation Pharmaceutical industry employment issues HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2009-04-16T13:39:16-04:00
753341 MASSACHUSETTS MEDICAL SOCIETY e3542640-e726-4343-8c47-db6b637728d5 Q1 MASSACHUSETTS MEDICAL SOCIETY 23975 MASSACHUSETTS MEDICAL SOCIETY 2009 first_quarter PHA Biologicals legislation to establish standards for the FDA approval of biologically equivalent drugs (no contact no legislation) S. 301, Physician Payment Sunshine Act legislation which would require pharmaceutical companies and device manufactures to disclosure gifts and other contributions to physicians Centers For Medicare and Medicaid Services (CMS),Federal Trade Commission (FTC),HOUSE OF REPRESENTATIVES,SENATE   80000 0 0 2009-04-16T14:28:49-04:00
753477 RYAN MACKINNON VASAPOLI AND BERZOK, LLP 0de3b613-9087-4c88-a5ab-00ecf84b74fb Q1 RYAN MACKINNON VASAPOLI AND BERZOK, LLP 30187 MERCK & CO 2009 first_quarter PHA Congressional oversight relating to Vioxx and Vytorin and matters relating to healthcare reform. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2009-04-16T14:48:42-04:00
753482 AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS ca799938-68dc-4df2-babf-d91889bac0b3 Q1 AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS 3457 AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS 2009 first_quarter PHA Communication seeking withdrawal of propxyphene from the market. Communication re: experimental study of consumer reporting of side effects as part of direct-to-consumer advertising. Communication re: evaluation and usefulness of consumer medication information. Communication re: FDA's Sentinal Initiative to monitor medical product safety. Comments on disposal of controlled substances. Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),Environmental Protection Agency (EPA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office   250000 0 0 2009-04-16T14:49:44-04:00
753622 AMERICAN VETERINARY MEDICAL ASSOCIATION b5cade5a-aebd-4797-a0af-c886438a7980 Q1 AMERICAN VETERINARY MEDICAL ASSOCIATION 3630 AMERICAN VETERINARY MEDICAL ASSOCIATION 2009 first_quarter PHA HR 1549/S 619, Preservation of Antibiotics for Medical Treatment Act Agriculture, Dept of (USDA),Executive Office of the President (EOP),Federal Trade Commission (FTC),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   170000 0 0 2009-04-16T15:04:30-04:00
753718 VAN SCOYOC ASSOCIATES 33ce6c47-04bd-49ff-8ff4-438ea8ee25f9 Q1 VAN SCOYOC ASSOCIATES 39837 UNIVERSITY OF MARYLAND BALTIMORE 2009 first_quarter PHA Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2010, FDA salaries and expenses; and extramural research related issues. Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2009-04-16T15:14:11-04:00
753804 DUANE MORRIS GOVERNMENT AFFAIRS a412a977-91dd-46b4-9aa5-0b0b081a743f Q1 DUANE MORRIS GOVERNMENT AFFAIRS 49657 CB DISTRIBUTORS INC 2009 first_quarter PHA Regulation of over-the-counter asthma-cough medicines. Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2009-04-16T15:28:43-04:00
753831 VAN SCOYOC ASSOCIATES 141998fc-0ab7-4c25-9ebe-3e7159298052 Q1 VAN SCOYOC ASSOCIATES 39837 UNIVERSITY OF PENNSYLVANIA SCHOOL OF MEDICINE 2009 first_quarter PHA Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2010, FDA and USDA funding initiatives. Public Law 111-8, Omnibus Appropriations Act, FY2009, FDA and USDA funding initiatives. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2009-04-16T15:32:58-04:00
753842 AMERICAN COLLEGE OF CLINICAL PHARMACY f802f154-6f00-4946-ab67-860823c86238 Q1 AMERICAN COLLEGE OF CLINICAL PHARMACY 57258 AMERICAN COLLEGE OF CLINICAL PHARMACY 2009 first_quarter PHA Coverage for direct patient care services of qualified pharmacists under Medicare Part B. Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE   61950 0 0 2009-04-16T15:34:05-04:00
753969 PARRY, ROMANI, DECONCINI & SYMMS 6adb1bc4-ac51-481a-a743-3503e833766e Q1 PARRY, ROMANI, DECONCINI & SYMMS 30792 BRAIDWOOD MANAGEMENT, INC. 2009 first_quarter PHA Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation has been introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation has been introduced yet. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2009-04-16T15:49:57-04:00
754045 OGR 7173b0e0-9ba3-48d1-8f5e-245f83a0f164 Q1 OGR 48827 SANOFI PASTEUR 2009 first_quarter PHA vaccine related issues HOUSE OF REPRESENTATIVES 20000   0 0 2009-04-16T15:58:27-04:00
754411 PARRY, ROMANI, DECONCINI & SYMMS 7c5a6c87-4ca1-4d24-be4b-5012e093ba40 Q1 PARRY, ROMANI, DECONCINI & SYMMS 30792 INTL ACADEMY OF COMPOUNDING PHARMACISTS 2009 first_quarter PHA Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation has been introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation has been introduced yet. HOUSE OF REPRESENTATIVES,SENATE 15000   0 0 2009-04-16T17:05:27-04:00
754880 WINSTON & STRAWN LLP 58a36742-89cd-4fad-b12f-f3d9a61337e9 Q1 WINSTON & STRAWN LLP 41682 FRESENIUS KABI USA (FORMERLY KNOWN AS APP PHARMACEUTICALS INC ) 2009 first_quarter PHA Represent the client on issues related to assuring a safe supply of heparin. Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE     0 0 2009-04-16T19:55:56-04:00
755164 EISAI INC. 093df4a1-fd2d-4b1c-b5c9-61cc28aea0a8 Q1 EISAI INC. 400321512 EISAI INC. 2009 first_quarter PHA HR 1427, Promoting Innovation and Access to Life-Saving Medicine Act HR 1548, Pathway for Biosimilars Act of 2009 S. 726, Promoting Innovation and Access to Life-Saving Medicine Act HOUSE OF REPRESENTATIVES,SENATE   620000 0 0 2009-04-17T09:55:05-04:00
755601 ANIMAL HEALTH INSTITUTE eb04e1a3-f24f-42b7-b79f-147948f96bbd Q1 ANIMAL HEALTH INSTITUTE 4037 ANIMAL HEALTH INSTITUTE 2009 first_quarter PHA Antimicrobial Resistance; HR 1549, S619, Preservation of Antibiotics for Medical Treatment Act HOUSE OF REPRESENTATIVES,SENATE   25000 0 0 2009-04-17T11:00:34-04:00
755659 BLUE CROSS BLUE SHIELD OF MICHIGAN 8db204cc-4b4d-44ad-9039-41c5826199e4 Q1 BLUE CROSS BLUE SHIELD OF MICHIGAN 46676 BLUE CROSS BLUE SHIELD OF MICHIGAN 2009 first_quarter PHA Biogenerics/Generic Biologics: HR1427 "Promoting Innovation and Access to Life-Saving Medicine Act" HOUSE OF REPRESENTATIVES,SENATE   30000 0 0 2009-04-17T11:07:42-04:00
755849 GEPHARDT GROUP GOVERNMENT AFFAIRS d41c25ed-f594-4bc6-a5a2-b87f89d2fbe2 Q1 GEPHARDT GROUP GOVERNMENT AFFAIRS 315717 THE MEDICINES COMPANY 2009 first_quarter PHA patent issue HOUSE OF REPRESENTATIVES,SENATE 250000   0 0 2009-04-17T11:25:55-04:00
755957 BROYDRICK & ASSOCIATES 0aa7ee5b-d900-4454-bbf2-6acffeff6609 1T BROYDRICK & ASSOCIATES 7268 BARR LABORATORIES 2009 first_quarter PHA Patent reform, Generic Biologies HOUSE OF REPRESENTATIVES,SENATE     0 1 2009-04-17T11:40:12-04:00
756032 PARRY, ROMANI, DECONCINI & SYMMS 90069468-7d88-48aa-820f-a04286ff11fa Q1 PARRY, ROMANI, DECONCINI & SYMMS 30792 VETERINARY PHARMACIES OF AMERICA, INC. 2009 first_quarter PHA Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation introduced yet. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2009-04-17T11:45:16-04:00
756188 PARRY, ROMANI, DECONCINI & SYMMS d0f0b59a-fffb-4ec1-b304-9cb3a98a6e42 Q1 PARRY, ROMANI, DECONCINI & SYMMS 30792 WEDGEWOOD VILLAGE PHARMACY, INC. 2009 first_quarter PHA Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation introduced yet. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2009-04-17T12:00:28-04:00
756200 VAN NESS FELDMAN, LLP 35b0d85f-c87d-4b9b-a67b-094321612718 Q1 VAN NESS FELDMAN, LLP 39815 MCKESSON CORPORATION 2009 first_quarter PHA S. 256, Combat Methamphetamine Enhancement Act of 2009 S. 525, A bill to amend the Federal Food, Drug, and Cosmetic Act Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2009-04-17T12:01:38-04:00
756219 FABIANI & COMPANY 834ede01-7433-405a-b09e-ebfbe97091c8 Q1 FABIANI & COMPANY 72576 ACORDA THERAPEUTICS, INC. 2009 first_quarter PHA Educate members and staff about Acordas products. Secure funding through the annual appropriation process for research. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2009-04-17T12:02:43-04:00
756366 PARRY, ROMANI, DECONCINI & SYMMS 68ce1eba-39a1-4701-8286-1d8d1d5833fe Q1 PARRY, ROMANI, DECONCINI & SYMMS 30792 WOMEN'S INTERNATIONAL PHARMACY, INC. 2009 first_quarter PHA Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation introduced yet. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2009-04-17T12:13:36-04:00
756391 THE UNITED STATES PHARMACOPEIAL CONVENTION d2a68dd2-37f7-434b-a489-87b55473e1ec Q1 THE UNITED STATES PHARMACOPEIAL CONVENTION 400358632 THE UNITED STATES PHARMACOPEIAL CONVENTION 2009 first_quarter PHA -GAO Study on Dietary Supplement Regulation, provided comments for. -HR 759 "The Food and Drug Administration Globalization Act of 2009", regarding provisions on drugs and food ingredients with specific reference to drug quality, food quality and compendial modernization. -Letter to DHHS Secretary Designate regarding FDA Mission on drug quality, food quality, standards and follow-on biologics. -Letter to Acting Commissioner of FDA regarding FDA budget and standards. -Communication with Congress on standards of use for heparin and glycerin. -Communication with FDA regarding drug quality, food quality and follow-on biologics and FDA resources. -Letter to Congress on legislative issues before Congress regarding drug quality, food quality and follow-on biologics and FDA resources. -Provided information to Congress for a hearing on drug issues regarding intellectual property issues for drugs. -HR 1298 "Pharmaceutical Market Access & Drug Safety Act of 2009", regarding all provisions on the effect of re-importation provisions on FDA requirements and USP Compendial Standards for Drugs. -Letter to FDA Commissioner-Designate regarding FDA resources, drug quality and food quality. -HR 1427 / S 726 "Promoting Innovation and Access to Lifesaving Medicine Act", regarding all provisions on biologics; role and importance of standards, follow-on biologics. -HR 1548 "Pathway for Biosimilars Act", regarding all provisions on biologics; role of importance of standards, follow-on biologics. -HR 1105 "FY 2009 Omnibus Appropriations Act", regarding provisions on verification programs, standards and resources for FDA. Congressional Budget Office (CBO),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,President of the U.S.,SENATE   100000 0 0 2009-04-17T12:18:28-04:00
756414 BLUE CROSS AND BLUE SHIELD OF KANSAS, INC. 9410a679-f763-4832-8f42-4f1c26ade683 Q1 BLUE CROSS AND BLUE SHIELD OF KANSAS, INC. 323876 BLUE CROSS AND BLUE SHIELD OF KANSAS INC 2009 first_quarter PHA Biogenerics/Generic Biologics: HR1427 "Promoting Innovation and Access to Life-Saving Medicine Act" HOUSE OF REPRESENTATIVES,SENATE     0 0 2009-04-17T12:20:53-04:00
756604 THE OB-C GROUP, LLC 67f6d0f4-a4e4-47c5-a11d-7b6e49394d0b Q1 THE OB-C GROUP, LLC 29802 ELI LILLY 2009 first_quarter PHA HR 1548, Pathway for Biosimilars Act; entire bill. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2009-04-17T12:41:59-04:00
756756 APOTEX CORP. 8c893a3c-af3b-4759-a29a-5e890c8df6cb Q1 APOTEX CORP. 310973 APOTEX CORP. 2009 first_quarter PHA S. 369, the Preserve Access to Affordable Generics Act HR 1706, the Protecting Consumer Access to Generic Drugs Act HR 1427, the Promoting Innovation and Access to Life Saving Medicine Act S. 726, the Promoting Innovation and Access to Life Saving Medicine Act HR 1548, Pathway for Biosimilars Act S. 501, the Fair Prescription Drug Competition Act HR 573 concerning authorized generics Federal Trade Commission (FTC),HOUSE OF REPRESENTATIVES,SENATE   130000 0 0 2009-04-17T13:00:41-04:00
756806 UNIVERSITY OF IOWA 007eef46-69ad-4ed8-925e-0cf73ef85232 Q1 UNIVERSITY OF IOWA 49191 UNIVERSITY OF IOWA 2009 first_quarter PHA Increased appropriations for systems to shorten the time between development of a drug and its release to the public. FDA reform as it relates to drug development and research Collaborative research on drug development anti-malarial pharmaceuticals FY2009 and FY 2010 Agricultural Appropriations human factors research related to neuropharmaceuticals Agriculture, Dept of (USDA),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Office of Management & Budget (OMB),Office of Science & Technology Policy (OSTP),SENATE,State, Dept of (DOS),Transportation, Dept of (DOT)   110000 0 0 2009-04-17T13:03:00-04:00
756914 EVERGREEN ASSOCIATES, LTD. 7cd260b9-a665-486c-8733-1c597c97c49c Q1 EVERGREEN ASSOCIATES, LTD. 13984 PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION 2009 first_quarter PHA Risk Communications: Consumer Medication Information, Medication Guides, Patient Package Inserts, Professional Inserts Food & Drug Administration (FDA)     0 0 2009-04-17T13:14:55-04:00
757162 FABIANI & COMPANY aef3b341-0b2f-4a12-bb5b-5d9ef1facc77 Q1 FABIANI & COMPANY 72576 ALNYLAM PHARMACEUTICALS 2009 first_quarter PHA S.515 Patent Reform Act Provisions relating to the apportionment of damages HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2009-04-17T13:54:22-04:00
757172 DUANE MORRIS GOVERNMENT AFFAIRS 8fedc1fd-402b-48d3-bbbf-5fa31a832408 Q1 DUANE MORRIS GOVERNMENT AFFAIRS 49657 LEHIGH VALLEY TECHNOLOGIES 2009 first_quarter PHA Monitor Federal activity relating to pharmaceutical manufacturing. Drug Enforcement Administration (DEA),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2009-04-17T13:55:23-04:00
757474 FABIANI & COMPANY 92daf5ef-2af7-4b84-9803-61c47b238b83 Q1 FABIANI & COMPANY 72576 VAXINNATE 2009 first_quarter PHA Department of Defense Appropriations Act of 2009, provisions relating to funding for novel flu vaccine development Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2009-04-17T14:21:11-04:00
757507 JOHNS HOPKINS UNIVERSITY 47622a39-6c4d-485a-8a9d-4b740837528f Q1 JOHNS HOPKINS UNIVERSITY 20664 JOHNS HOPKINS UNIVERSITY 2009 first_quarter PHA H.R. 444, 340B Program Improvement and Integrity Act of 2009. Issues regarding extending 340B outpatient pharmaceutical discount to the inpatient setting. HOUSE OF REPRESENTATIVES,SENATE   190000 0 0 2009-04-17T14:22:27-04:00
757565 GENENTECH, INC 29c35e66-7f8d-4461-a383-4c23b0342141 Q1 GENENTECH, INC 15920 GENENTECH INC 2009 first_quarter PHA H.R. 1427 Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548 Pathway for Biosimilars Act of 2009 S. 726 Promoting Innovation and Access to Life-Saving Medicine Act Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   700000 0 0 2009-04-17T14:25:44-04:00
758242 FOLEY HOAG LLP 115e1d30-863e-4828-9225-c465c726f81b Q1 FOLEY HOAG LLP 79610 GLAXOSMITHKLINE 2009 first_quarter PHA Drug Safety; Prevention and Chronic Disease Management Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 75000   0 0 2009-04-17T15:20:37-04:00
758266 INDEPENDENCE BLUE CROSS b629af99-4ede-4daf-8926-eec746931704 Q1 INDEPENDENCE BLUE CROSS 19172 INDEPENDENCE BLUE CROSS 2009 first_quarter PHA Biogenerics/Generic Biologics: HR1427 "Promoting Innovation and Access to Life-Saving Medicine Act" HOUSE OF REPRESENTATIVES,SENATE,White House Office     0 0 2009-04-17T15:21:40-04:00
758322 US STRATEGIES 01614ff3-4302-4417-b07f-1ece3904074a Q1 US STRATEGIES 38825 NOVOLOGIX (FORMERLY ANCILLARY CARE MANAGEMENT) 2009 first_quarter PHA Medicare and Medicaid provisions relating to pharmacy and medication management policies HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2009-04-17T15:23:53-04:00
758583 ALCALDE & FAY cdea555a-7045-435b-b2c8-dd8096bc4485 Q1 ALCALDE & FAY 818 XSTREAM SYSTEMS, INC. 2009 first_quarter PHA Bringing awareness of the pharmaceutical authentication product to Committees of Congress and federal agencies; Seek to include an authentication provision in legislation addressing counterfeit drugs, pharmaceutical importation, and pharmaceutical distribution including H.R.1298, S.80, and S.525 Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,Veterans Affairs, Dept of (VA) 20000   0 0 2009-04-17T15:40:38-04:00
758631 PARRY, ROMANI, DECONCINI & SYMMS a119b6ec-b3b3-4a0f-aa42-1aa0b1ee0822 Q1 PARRY, ROMANI, DECONCINI & SYMMS 30792 SUNOVION PHARMACEUTICALS INC (FORMERLY SEPRACOR INC ) 2009 first_quarter PHA No specific legislation or bills introduced at this time. Medicare reimbursement issues. HOUSE OF REPRESENTATIVES,SENATE 55000   0 0 2009-04-17T15:42:50-04:00
758815 BLUE CROSS AND BLUE SHIELD OF FLORIDA, INC. afcea7b3-db60-4900-9460-081a7451caea Q1 BLUE CROSS AND BLUE SHIELD OF FLORIDA, INC. 6382 BLUE CROSS AND BLUE SHIELD OF FLORIDA INC 2009 first_quarter PHA Biogenerica/Generic Biologics: H.R.1427 "Promoting Innovation and Access to Life-Saving Medicine Act" HOUSE OF REPRESENTATIVES,SENATE   320000 0 0 2009-04-17T16:00:22-04:00
758831 MEDCO HEALTH SOLUTIONS, INC 61ae7415-2ea1-459f-b1a8-a740351049d9 Q1 MEDCO HEALTH SOLUTIONS, INC 89177 MEDCO HEALTH SOLUTIONS INC 2009 first_quarter PHA Electronic Prescribing, Mail Order Pharmacy HR 1 - American Recovery and Reinvestment Act of 2009; Title XIII - Health Information Technology for Economic and Clinical Health Act or the HITECH Act Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   990000000 0 0 2009-04-17T16:01:09-04:00
758833 MCDERMOTT WILL & SCHULTE LLP e0d46e59-b562-436f-af46-22df3e59b128 Q1 MCDERMOTT WILL & SCHULTE LLP 24338 RURAL REFERRAL CENTER/SOLE COMMUNITY HOSPITAL COALITION 2009 first_quarter PHA Amendments to Section 340(b) of the Public Health Service Act to gain eligibility for rural referral centers and sole community hospitals in the federal discount drug purchasing program; seeking to advance H.R. 444. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 70000   0 0 2009-04-17T16:01:24-04:00
758997 KNIGHT CAPITOL CONSULTANTS 05006b54-c277-445a-a8f9-4c9a26974303 Q1 KNIGHT CAPITOL CONSULTANTS 40036301 SANOFI US SERVICES INC (FORMERLY KNOWN AS "SANOFI-AVENTIS U S INC ) 2009 first_quarter PHA Monitor general issues of interest to pharmaceutical industry (no specific bills) HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2009-04-17T16:17:01-04:00
759155 BLUECROSS BLUESHIELD OF TENNESSEE 189f5dc8-f0ca-4f02-acb8-16fdcb4f3323 Q1 BLUECROSS BLUESHIELD OF TENNESSEE 6440 BLUECROSS BLUESHIELD OF TENNESSEE 2009 first_quarter PHA Biologicals S.623 E-Prescribing - Enhanced Health Care Value for All Act Comparative Effectiveness Research Act HOUSE OF REPRESENTATIVES,SENATE   40000 0 0 2009-04-17T16:27:34-04:00
759180 AMYLIN PHARMACEUTICALS 05cc7365-91e9-4c77-b24a-8147365f6bcc Q1 AMYLIN PHARMACEUTICALS 308536 AMYLIN PHARMACEUTICALS 2009 first_quarter PHA S. 301, Physician Payments Sunshine Act of 2009 H.R. 1548, Pathway for Biosimilars Act H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act S. 726, Promoting Innovation and Access to Life-Saving Medicine Act Drug Importation/Drug Safety H.R. 759, Food and Drug Administration Globalization Act of 2009 Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   350000 0 0 2009-04-17T16:29:46-04:00
759247 AARP f8014bec-1a9f-405a-9508-6ba92b683cb7 Q1 AARP 1694 AARP 2009 first_quarter PHA S.525/H.R. 1298, Pharmaceutical Market Access and Drug Safety Act of 2009 - Discussed legislation which would create a system of safe importation of prescription drugs from abroad. S.726/H.R.1427, Promoting Innovation and Access to Life-Saving Medicine Act - Discussed legislation which would create a pathway for the approval of safe, effective biosimilar and generic biologic drugs. H.R.1706, Protecting Consumer Access to Generic Drugs Act of 2009 - Discussed legislation that would prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and for other purposes. S. 369, Preserve Access to Affordable Generics Act - Discussed legislation that would prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market,and for other purposes. S.515/H.R.1260, Patent Reform Act of 2009 - Discussed legislation that would amend federal patent law to rewrite provisions concerning the conditions for patentability. Specifically, AARP weighed in on the inequitable conduct provisions of the legislation. S. 301, Physician Payments Sunshine Act of 2009 - Discussed legislation that would provide for disclosure of gifts given by pharmaceutical and device manufacturers to physicians. Commerce, Dept of (DOC),Federal Communications Commission (FCC),Federal Reserve System,Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),Labor, Dept of (DOL),Office of the Vice President of the United States,Securities & Exchange Commission (SEC),SENATE,Social Security Administration (SSA),Transportation, Dept of (DOT),Treasury, Dept of,White House Office   4080000 0 0 2009-04-17T16:34:40-04:00
759391 BUCHANAN INGERSOLL & ROONEY PC e0af7e22-ba69-4c6a-8450-c3f6efe6f1b1 Q1 BUCHANAN INGERSOLL & ROONEY PC 55291 BIOFACTURA 2009 first_quarter PHA Biotechnology, Disaster Planning, Homeland Security, Science & Technology and Pharmacy issues with the US House, US Senate and Federal Agencies Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2009-04-17T16:51:10-04:00
759884 UNIVERSITY OF KANSAS 91e7f92b-4092-451a-a8bf-bc16ff1a22fc Q1 UNIVERSITY OF KANSAS 321373 UNIVERSITY OF KANSAS 2009 first_quarter PHA Contacted congressional delegation regarding multi-university pharmaceutical research consortium Army, Dept of (Other),Defense, Dept of (DOD),Education, Dept of,Energy, Dept of,HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Securities & Exchange Commission (SEC),SENATE   172000 0 0 2009-04-17T18:18:07-04:00
760792 PODESTA GROUP, INC. 3bb866a5-f3f3-4fbd-ad84-1b03f283a732 Q1 PODESTA GROUP, INC. 31680 BRISTOL-MYERS SQUIBB 2009 first_quarter PHA H.R. 1427 Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548 Pathyway for Biosimilars Act S. 726 Promoting Innovation and Access to Life-Saving Medicine Act Drug Importation/Drug Safety Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2009-04-19T06:24:42-04:00
760798 PODESTA GROUP, INC. 0c527686-fe05-40fd-8e2c-ee987fe7c735 Q1 PODESTA GROUP, INC. 31680 CUBIST PHARMACEUTICALS INC 2009 first_quarter PHA Medical Research Prescription drug/Federal Drug Admin/Center for Disease Control/Health and Human Service issues Antibiotic Resistance issues Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 70000   0 0 2009-04-19T06:40:45-04:00
760802 PODESTA GROUP, INC. 55f08704-b0a6-40b5-bfc6-34abb95c8365 Q1 PODESTA GROUP, INC. 31680 WINNING STRATEGIES WASHINGTON LLC 2009 first_quarter PHA Medicare, Durable Equipment, Prosthetics, Orthotics and Supplies - Competitive Bidding Program Issues. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2009-04-19T06:47:47-04:00
760808 PODESTA GROUP, INC. 4314531e-bcca-4a90-a803-1ffff86c1fe9 Q1 PODESTA GROUP, INC. 31680 EISAI INC. 2009 first_quarter PHA H.R. 1427 Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548 Pathway for Biosimilars Act S. 726 Promoting Innovation and Access to Life-Saving Medicine Act HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2009-04-19T06:52:50-04:00
760814 PODESTA GROUP, INC. b7793f59-882d-4b71-a9ee-2702c8b8057c Q1 PODESTA GROUP, INC. 31680 EMD SERONO INC 2009 first_quarter PHA H.R. 1427 Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548 Pathway for Biosimilars Act S. 726 Promoting Innovation and Access to Life-Saving Medicine Act Drug importation HOUSE OF REPRESENTATIVES,Patent & Trademark Office (PTO),SENATE 60000   0 0 2009-04-19T06:58:51-04:00
760824 PODESTA GROUP, INC. 0b93179d-a682-4166-a64f-d7f7558fdddf Q1 PODESTA GROUP, INC. 31680 GENENTECH 2009 first_quarter PHA H.R. 1427 Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548 Pathway for Biosimilars Act of 2009 S. 726 Promoting Innovation and Access to Life-Saving Medicine Act Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2009-04-19T07:01:55-04:00
760835 PODESTA GROUP, INC. 770912b7-da49-42a4-b2fb-26b6bb5a91c1 Q1 PODESTA GROUP, INC. 31680 GENZYME 2009 first_quarter PHA H.R. 1427 Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548 Pathway for Biosimilars Act S. 726 Promoting Innovation and Access to Life-Saving Medicine Act Neglected Disease Issues Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 130000   0 0 2009-04-19T07:21:01-04:00
760844 PODESTA GROUP, INC. 0bf5d49b-3182-4183-87ee-398369a5b8e9 Q1 PODESTA GROUP, INC. 31680 THE UNIVERSITY OF TEXAS M.D. ANDERSON CANCER CENTER 2009 first_quarter PHA Patient safety, animal research, clinical trials, scientific misconduct, conflict of interest HOUSE OF REPRESENTATIVES,SENATE 110000   0 0 2009-04-19T08:18:28-04:00
760853 PODESTA GROUP, INC. ab9268a8-c3b7-49f6-a23f-8a5a6e65251c Q1 PODESTA GROUP, INC. 31680 MILLENNIUM PHARMACEUTICALS INC 2009 first_quarter PHA H.R. 1427 Promoting Innovation and Access to Life-Saving Medicine H.R. 1548 Pathway for Biosimilars Act S. 726 Promoting Innovation and Access to Life-Saving Medicine Act Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2009-04-19T08:25:32-04:00
760869 PODESTA GROUP, INC. aa873348-60f8-4128-97db-846a4e2d1be0 Q1 PODESTA GROUP, INC. 31680 NOVO NORDISK INC 2009 first_quarter PHA H.R. 1427 Promoting Innovation and Access to Life-Saving Medicine H.R. 1548 Pathway for Biosimilars Act S. 726 Promoting Innovation and Access to Life-Saving Medicine Act Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 60000   0 0 2009-04-19T08:46:44-04:00
760928 WALMART INC. 0f65a6e7-34a8-4c95-be42-9c81df4f208d Q1 WALMART INC. 40305 WALMART INC 2009 first_quarter PHA H.R. 1548 & S. 1427, Legislation amending title XIX of the Society Security Act to ensure that individuals eligible for medical assistance under the Medicaid Program continue to have access to prescription drugs, and for other purposes Average Manufacturers Price Consumer Product Safety Commission (CPSC),Council on Environmental Quality (CEQ),Energy, Dept of,Federal Energy Regulatory Commission (FERC),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),Office of Natl Drug Control Policy (NDCP),SENATE,U.S. Customs & Border Protection,U.S. Trade Representative (USTR),White House Office   1522308 0 0 2009-04-19T10:22:53-04:00
761264 RUBICON ADVISORS, LLC 72beb5da-b26a-425c-8c7f-05ab95ff1d05 1T RUBICON ADVISORS, LLC 315091 AMERICAN SOCIETY OF INTERVENTIONAL PAIN PHYSICIANS 2009 first_quarter PHA Healthcare: Medicare Reimbursement, Centers for Medicare & Medicaid Services   30000   0 1 2009-04-19T15:52:03-04:00
761273 SHIRE PHARMACEUTICALS LLC 1b9ae847-fdb1-407d-b345-88e9b406613f Q1 SHIRE PHARMACEUTICALS LLC 323477 SHIRE PHARMACEUTICALS LLC 2009 first_quarter PHA H.R. 1548, Pathway for Biosimilars Act, provisions relating to ultra-orphan biologics. H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act, provisions relating to ultra-orphan biologics. HOUSE OF REPRESENTATIVES,SENATE   100000 0 0 2009-04-19T15:54:06-04:00
761275 RUBICON ADVISORS, LLC e7de48d7-f93d-4301-934c-40dccb4ce80b Q1 RUBICON ADVISORS, LLC 315091 BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. 2009 first_quarter PHA Physician Payment Sunshine Act S. 2029 Patent Settlements H.R. 1432S. 316   30000   0 0 2009-04-19T15:55:07-04:00

Next page

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE lobbying_activities (
            id INTEGER PRIMARY KEY,
            filing_uuid TEXT NOT NULL,
            filing_type TEXT NOT NULL,
            registrant_name TEXT NOT NULL,
            registrant_id INTEGER,
            client_name TEXT NOT NULL,
            filing_year INTEGER NOT NULL,
            filing_period TEXT NOT NULL,
            issue_code TEXT,
            specific_issues TEXT,
            government_entities TEXT,
            income_amount INTEGER,
            expense_amount INTEGER,
            is_no_activity INTEGER DEFAULT 0,
            is_termination INTEGER DEFAULT 0,
            received_date TEXT,
            CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
                REFERENCES lobbying_filings_raw(filing_uuid)
        );
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);
Powered by Datasette · Queries took 1992.783ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API